INBS
Intelligent Bio Solutions Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$2.23
−3.04%Income statement
| Metric | TTM | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 4.2M | 4.2M | 3.1M | 3.1M | 1.3M |
| Cost of Revenue | 3.0M | 2.2M | 1.8M | 1.7M | 930.2K |
| Gross Profit | 1.2M | 2.0M | 1.2M | 1.4M | 326.7K |
| Operating Expenses | |||||
| R&D Expense | 3.4M | 3.4M | 2.4M | 1.7M | 507.4K |
| SG&A Expense | 10.4M | 10.5M | 8.9M | 9.3M | 8.0M |
| General & Admin Expense | 2.3M | 10.5M | 7.3M | 8.5M | — |
| Selling & Marketing Expense | — | — | 1.6M | 725.4K | — |
| Other Expenses | 209.2K | 784.6K | 611.0K | 776.5K | 4.4M |
| Total Operating Expenses | 14.0M | 14.7M | 11.9M | 11.7M | 12.9M |
| Cost and Expenses | 17.1M | 16.8M | 13.7M | 13.4M | 13.9M |
| Operating Income (EBIT) | (12.9M) | (12.6M) | (10.6M) | (10.3M) | (12.6M) |
| Non-Operating | |||||
| Interest Income | 110.3K | 110.3K | 101.5K | 84.8K | 9.7K |
| Interest Expense | 67.7K | 10.7K | 60.9K | 167.1K | 223.5K |
| Net Interest Income | 42.7K | 99.6K | 40.6K | (82.3K) | (214.0K) |
| Other Non-Op Income/Expense | 389.0K | 139.4K | 39.7K | 92.2K | 1.9M |
| Non-Operating Income (excl Interest) | (160.4K) | (150.1K) | (220.1K) | (259.4K) | (2.2M) |
| EBT (Pre-Tax Income) | (12.5M) | (12.5M) | (10.6M) | (10.2M) | (10.7M) |
| Income Tax Expense | — | — | — | — | — |
| Bottom Line | |||||
| Net Income | (12.4M) | (12.4M) | (10.6M) | (10.2M) | (10.6M) |
| Earnings from Cont. Ops | (12.5M) | (12.5M) | (10.6M) | (10.2M) | (10.7M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (12.4M) | (12.4M) | (10.6M) | (10.2M) | (10.6M) |
| Per Share | |||||
| Basic EPS | ($9.46) | ($8.44) | ($20.00) | ($63.80) | ($105.80) |
| Diluted EPS | ($9.46) | ($8.44) | ($20.00) | ($63.80) | ($105.80) |
| Revenue Per Share | $1.45 | $2.86 | $5.79 | $9.77 | $6.26 |
| Shares | |||||
| Basic Shares Outstanding | 2.9M | 1.5M | 527364 | 318500 | 200900 |
| Diluted Shares Outstanding | 2.9M | 1.5M | 527364 | 318500 | 200900 |
| Profitability Metrics | |||||
| EBITDA | (11.5M) | (11.3M) | (9.5M) | (9.0M) | (9.5M) |
| D&A | 1.2M | 1.2M | 970.1K | 974.4K | 966.7K |
| EBIT | (12.7M) | (12.5M) | (10.4M) | (10.0M) | (10.4M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026